Cardiac xenotransplantation: from concept to clinic
Cardiovascular Research · 03.02.2023 · 118 (18) · 3499-3516
DOI: 10.1093/cvr/cvac180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 03.12.2022. Verfasst von Bruno Reichart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Walter Brendel Centre for Experimental Medicine, Ludwig-Maximilians-Universität München, Munich 81377, Germany. Hauptthemen laut MEDLINE: Quality of Life, Heart Transplantation. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
For many patients with terminal/advanced cardiac failure, heart transplantation is the most effective, durable treatment option, and offers the best prospects for a high quality of life. The number of potentially life-saving donated human organs is far fewer than the population who could benefit from a new heart, resulting in increasing numbers of patients awaiting replacement of their failing heart, high waitlist mortality, and frequent reliance on interim mechanical support for many of those deemed among the best candidates but who are deteriorating as they wait. Currently, mechanical assist devices supporting left ventricular or biventricular heart function are the only alternative to heart transplant that is in clinical use. Unfortunately, the complication rate with mechanical assistance remains high despite advances in device design and patient selection and management, and the quality of life of the patients even with good outcomes is only moderately improved. Cardiac xenotransplantation from genetically multi-modified (GM) organ-source pigs is an emerging new option as demonstrated by the consistent long-term success of heterotopic (non-life-supporting) abdominal and life-supporting orthotopic porcine heart transplantation in baboons, and by a recent ‘compassionate use’ transplant of the heart from a GM pig with 10 modifications into a terminally ill patient who survived for 2 months. In this review, we discuss pig heart xenotransplantation as a concept, including pathobiological aspects related to immune rejection, coagulation dysregulation, and detrimental overgrowth of the heart, as well as GM strategies in pigs to prevent or minimize these problems. Additional topics discussed include relevant results of heterotopic and orthotopic heart transplantation experiments in the pig-to-baboon model, microbiological and virologic safety concepts, and efficacy requirements for initiating formal clinical trials. An adequate regulatory and ethical framework as well as stringent criteria for the selection of patients will be critical for the safe clinical development of cardiac xenotransplantation, which we expect will be clinically tested during the next few years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Walter Brendel Centre for Experimental Medicine, Ludwig-Maximilians-Universität München, Munich 81377, Germany.
- Center for Transplantation Sciences, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129, USA.
- Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02114, USA.
- Department of Anaesthesiology, University Hospital, Ludwig-Maximilians-Universität München, Munich 81377, Germany.
- Division of Medical Biotechnology, Paul-Ehrlich-Institute, Langen 63225, Germany.
- Gene Centre and Centre for Innovative Medical Models (CiMM), Ludwig-Maximilians-Universität München, Munich 81377, Germany.
ORCID-Profile: Bruno Reichart, David K C Cooper, Matthias Längin, Ralf R Tönjes, Richard N Pierson, Eckhard Wolf
Förderung
- NIAID NIH HHS
- NIH HHS
- Deutsche Forschungsgemeinschaft
- Swiss National Science Foundation
- NIH
Zitieren
APA
Reichart, B., Cooper, D. K. C., Längin, M., Tönjes, R. R., Pierson, R. N., & Wolf, E. (2023). Cardiac xenotransplantation: from concept to clinic. Cardiovascular Research, 118(18), 3499-3516. https://doi.org/10.1093/cvr/cvac180
Vancouver
Reichart B, Cooper DKC, Längin M, Tönjes RR, Pierson RN, Wolf E. Cardiac xenotransplantation: from concept to clinic. Cardiovascular Research. 2023;118(18):3499-3516. doi:10.1093/cvr/cvac180
BibTeX
@article{Reichart2023,
author = {Reichart, Bruno and Cooper, David K C and Längin, Matthias and Tönjes, Ralf R and Pierson, Richard N and Wolf, Eckhard},
title = {Cardiac xenotransplantation: from concept to clinic},
journal = {Cardiovascular Research},
year = {2023},
volume = {118},
number = {18},
pages = {3499--3516},
doi = {10.1093/cvr/cvac180}
}
EUVIMED